Fertility Preservation

Fertility preservation services including ovarian stimulation with oocyte/embryo cryopreservation, ovarian tissue retrieval/cryopreservation, ovarian transposition, and sperm extraction/cryopreservation are covered for patients at risk of treatment‑related infertility (e.g., bilateral oophorectomy, gonadotoxic chemotherapy or radiation), including adolescents and select prepubertal patients (ovarian tissue) with counseling recommended prior to therapy. Coverage is subject to the member’s benefit plan, excludes voluntary sterilization, requires ovarian tissue to be free of malignancy, and deems several approaches (GnRH suppression, testicular tissue grafting, ovarian tissue reimplantation and other experimental methods) investigational or unsupported; oocyte/embryo cryopreservation is not appropriate if treatment cannot be delayed (~3 weeks) or for prepubertal patients.

"Patients undergoing bilateral oophorectomy with risk of loss of fertility."